“Oncology trials are different” states Dr Johann Proeve, our Chief Scientific Officer, in his latest video interview about “one-size doesn’t fit all” when it comes to risk management. Many risks in clinical trials seem therapy specific. To illustrate this, Johann shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.

Take a peek: Interview – Oncology Trials are Different

See also: Oncology Risk Assessment and Categorization Tool (OncoRACT)